Motif Neurotech
Motif Neurotech is a Neuromodulation & Stimulation company founded in 2020 and based in Houston, United States. It has raised $18.8M in total funding, most recently a Series A in 2024.
Develops magnetoelectric neural stimulation technology for non-invasive, deep-brain modulation targeting psychiatric and neurological disorders. Raised $15M Series A in 2023. Based on Rice University technology. Early clinical development for depression and other mood disorders.
Pioneering a novel stimulation modality that could reach deep brain structures without surgery or skull penetration, expanding the therapeutic reach of neuromodulation.
At a glance
Total raised
$18.8M
Headcount
11-50
Headquarters
Houston
United StatesFounded
2020
Status
Private
Subsector
Where Motif Neurotech ranks
Top 25 Brain-Computer Interfaces companies →Funding history
Total raised
$18.8M
Rounds tracked
1
Latest stage
Series A
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| Jan 24, 2024 | Series A | $18.8M | — | Arboretum Ventures |
